In the Ph+ subgroup, thrombocytopenia, lipase increase, neutropenia and hypophosphatemia, anemia, ALT increase, and bilirubin increase of grade 3 severity were experienced by 37 (3.9%), 30 (3.2%), 20 (2.1%), 19 (2%), 17 (1.8%), 14 (1.5%), and 13 (1.4%) patients, respectively. This evidence concerns the gene GPT and hypophosphatemia.